Catherine C. Park, MD

home / authors / catherine-c-park-md

Articles

ACR Appropriateness Criteria® Ductal Carcinoma in Situ

Seth A. Kaufman, MD;Eleanor E. R. Harris, MD;Lisa Bailey, MD;Manjeet Chadha, MD;Sharon C. Dutton, MD;Gary M. Freedman, MD;Sharad Goyal, MD;Michele Y. Halyard, MD;Kathleen C. Horst, MD;Kristina L. M. Novick, MD;Catherine C. Park, MD;W. Warren Suh, MD;Deborah Toppmeyer, MD;Jennifer Zook, MD;Bruce G. Haffty, MD

June 15th 2015

Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

The Current Clinical Value of the DCIS Score

William C. Wood, MD;Michael Alvarado, MD;Daniel J. Buchholz, MD;David Hyams, MD;E. Shelley Hwang, MD, MPH;Jennifer Manders, MD;Catherine C. Park, MD;Lawrence J. Solin, MD;Julia White, MD;Shawna Willey, MD

May 15th 2014

The DCIS Score provides clinically relevant information about personal risk that can guide patient discussions and facilitate shared decision making.

ACR Appropriateness Criteria® Local-Regional Recurrence (LRR) and Salvage Surgery-Breast Cancer

Michele Y. Halyard, MD;Eleanor E. R. Harris, MD;Lisa Bailey, MD;Jennifer R. Bellon, MD;Gary M. Freedman, MD;Sharad Goyal, MD;Kathleen C. Horst, MD;Meena S. Moran, MD;Catherine C. Park, MD;W. Warren Suh, MD;Deborah Toppmeyer, MD;Bruce G. Haffty, MD

February 15th 2014

Management recommendations for breast cancer local-regional recurrence (LRR), including patient scenarios, are reviewed, and represent evidence-based data and expert opinion of the American College of Radiology Appropriateness Criteria Expert Panel on LRR.